126 related articles for article (PubMed ID: 1706920)
1. Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level.
Kainoh M; Maruyama I; Nishio S; Nakadate T
Biochem Pharmacol; 1991 Apr; 41(8):1135-40. PubMed ID: 1706920
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP increases thrombomodulin expression on membrane surface of cultured human umbilical vein endothelial cells.
Ishii H; Kizaki K; Uchiyama H; Horie S; Kazama M
Thromb Res; 1990 Sep; 59(5):841-50. PubMed ID: 1700492
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of thrombomodulin on the cultured human umbilical vein endothelial cells and mouse hemangioma cells by cyclic AMP.
Maruyama I; Soejima Y; Osame M; Ito T; Ogawa K; Yamamoto S; Dittman WA; Saito H
Thromb Res; 1991 Feb; 61(3):301-10. PubMed ID: 1709310
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.
Crutchley DJ; Solomon DE; Conanan LB
Arterioscler Thromb; 1992 Jun; 12(6):664-70. PubMed ID: 1375507
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability.
Imai-Sasaki R; Kainoh M; Ogawa Y; Ohmori E; Asai Y; Nakadate T
Prostaglandins Leukot Essent Fatty Acids; 1995 Aug; 53(2):103-8. PubMed ID: 7480071
[TBL] [Abstract][Full Text] [Related]
6. Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities.
Archipoff G; Beretz A; Bartha K; Brisson C; de la Salle C; Froget-Léon C; Klein-Soyer C; Cazenave JP
Br J Pharmacol; 1993 May; 109(1):18-28. PubMed ID: 7684300
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways.
Niwano K; Arai M; Tomaru K; Uchiyama T; Ohyama Y; Kurabayashi M
Circ Res; 2003 Sep; 93(6):523-30. PubMed ID: 12919953
[TBL] [Abstract][Full Text] [Related]
8. The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP.
McKean JS; Murray F; Gibson G; Shewan DA; Tucker SJ; Nixon GF
Cardiovasc Res; 2015 Sep; 107(4):546-55. PubMed ID: 26092100
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of a synthetic prostacyclin analogue, beraprost, on urokinase-type plasminogen activator expression in RC-K8 human lymphoma cells.
Nomura N; Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Higashiyama K; Fujimaki M; Sakuragawa N
Thromb Haemost; 1996 Jun; 75(6):928-32. PubMed ID: 8822588
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells. Differences between up-regulation of thrombomodulin by retinoic acid and cyclic AMP.
Horie S; Kizaki K; Ishii H; Kazama M
Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):149-54. PubMed ID: 1370608
[TBL] [Abstract][Full Text] [Related]
11. cAMP inhibits cytokine-induced biosynthesis of tetrahydrobiopterin in human umbilical vein endothelial cells.
Ohtsuki M; Shiraishi H; Kato T; Kuroda R; Tazawa M; Sumi-Ichinose C; Tada S; Udagawa Y; Itoh M; Hishida H; Ichinose H; Nagatsu T; Hagino Y; Nomura T
Life Sci; 2002 Mar; 70(18):2187-98. PubMed ID: 12002810
[TBL] [Abstract][Full Text] [Related]
12. Adenosine 3':5'-cyclic monophosphate induces regulated secretion of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells.
Hegeman RJ; van den Eijnden-Schrauwen Y; Emeis JJ
Thromb Haemost; 1998 Apr; 79(4):853-8. PubMed ID: 9569204
[TBL] [Abstract][Full Text] [Related]
13. Effects of the prostaglandin I2 analogue, beraprost sodium, on vascular cell adhesion molecule-1 expression in human vascular endothelial cells and circulating vascular cell adhesion molecule-1 level in patients with type 2 diabetes mellitus.
Goya K; Otsuki M; Xu X; Kasayama S
Metabolism; 2003 Feb; 52(2):192-8. PubMed ID: 12601631
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of cyclooxygenase isoenzymes by cAMP-elevating agents.
Samokovlisky A; Rimon G; Danon A
Eur J Pharmacol; 1999 Aug; 378(2):203-11. PubMed ID: 10478633
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of endotoxin-induced cytotoxicity and prostacyclin production in cultured bovine pulmonary artery endothelial cells by phosphodiesterase inhibition.
Hussein A; Meyrick B; Graber S; Berry L; Brigham KL
Exp Lung Res; 1988; 14(5):637-54. PubMed ID: 2465143
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline prevents tumor necrosis factor-induced suppression of endothelial cell surface thrombomodulin.
Ohdama S; Takano S; Ohashi K; Miyake S; Aoki N
Thromb Res; 1991 Jun; 62(6):745-55. PubMed ID: 1656544
[TBL] [Abstract][Full Text] [Related]
17. U-61,431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells.
Shirotani M; Yui Y; Hattori R; Kawai C
Prostaglandins; 1991 Feb; 41(2):97-110. PubMed ID: 1708156
[TBL] [Abstract][Full Text] [Related]
18. A prostacyclin analog beraprost sodium attenuates radiocontrast media-induced LLC-PK1 cells injury.
Yano T; Itoh Y; Kubota T; Sendo T; Oishi R
Kidney Int; 2004 May; 65(5):1654-63. PubMed ID: 15086904
[TBL] [Abstract][Full Text] [Related]
19. Beraprost sodium, an analogue of prostacyclin, induces the expression of mitogen-activated protein kinase phosphatase and inhibits the proliferation of cultured mesangial cells.
Togawa M; Haneda M; Araki S; Sugimoto T; Isono M; Hidaka H; Yasuda H; Kashiwagi A; Kikkawa R
Eur J Pharmacol; 1997 Oct; 336(2-3):291-4. PubMed ID: 9384245
[TBL] [Abstract][Full Text] [Related]
20. Effect of beraprost sodium on the increased transendothelial permeation of albumin induced by high concentration of glucose.
Kobayashi K; Umeda F; Hashimoto T; Mimura K; Yamashita T; Nawata H
Fukuoka Igaku Zasshi; 1997 Mar; 88(3):44-8. PubMed ID: 9103700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
